Hetero and the Russian Direct Investment Fund (RDIF), which has been
backing the vaccine and marketing it globally, plan to start
production of Sputnik V in India at the beginning of 2021, the
statement said.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/russia-agrees-to-produce-coronavirus-vaccine-sputnik-v-in-india-set-to-work-with-hetero/articleshow/79441373.cms
No comments:
Post a Comment